Touchscreen Insulin Pump
Total Trials
13
As Lead Sponsor
2
As Collaborator
11
Total Enrollment
4,183
NCT02129595
Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Phase: N/A
Role: Collaborator
Start: Apr 30, 2014
Completion: Jul 31, 2017
NCT02565979
Long-term Resveratrol and Metabolism
Start: Apr 30, 2016
Completion: Mar 28, 2019
NCT03049228
In and ex Vivo Mitochondrial Function of the Heart
Start: Mar 21, 2017
Completion: Mar 2, 2020
NCT04013919
Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections
Role: Lead Sponsor
Start: Sep 20, 2019
Completion: Apr 30, 2020
NCT04043260
DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy
Start: Nov 27, 2019
Completion: Apr 30, 2021
NCT04653961
Evaluation of a Decision Support System for People With Diabetes Who Use Multiple Daily Insulin Injections- Feasibility and Proof of Concept Studies
Start: Jun 1, 2020
Completion: Oct 31, 2025
NCT04828304
PLASOMA Ultimate Safety & Efficacy Study
Start: May 26, 2021
Completion: Dec 16, 2024
NCT04183413
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini
Start: Nov 1, 2021
Completion: Dec 31, 2023
NCT06414824
The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes
Start: May 1, 2022
Completion: May 31, 2024
NCT05610722
Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1
Start: Nov 6, 2022
Completion: Sep 1, 2023
NCT06061042
Effect of Timed-Restricted Eating on Metabolic Health
Start: Oct 31, 2023
Completion: Dec 31, 2027
NCT06376240
The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes
Start: Mar 21, 2024
Completion: Dec 31, 2025
NCT06966427
Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections
Start: May 8, 2025
Completion: May 25, 2026
Loading map...